These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1942520)

  • 1. [Multiple discriminant analysis for prognosis of refractory anemia].
    Kobaba R; Kousaki M; Andou S; Okuda K; Tamura A; Miyazaki E; Inoue N; Okamoto T; Takemoto Y; Kanamaru A
    Rinsho Ketsueki; 1991 Aug; 32(8):815-21. PubMed ID: 1942520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of refractory anemia by high-dose methylprednisolone associated with an increment in CD68-positive cells in bone marrow.
    Motomura S; Motoji T; Okutomi K; Nishikawa T; Kasajima T; Mizoguchi H
    Am J Hematol; 2001 Feb; 66(2):80-4. PubMed ID: 11421303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-analysis of prognosis in refractory anemia alone, with ring sideroblasts, and with excess of blasts.
    Oguma S; Yoshida Y; Uchino H; Okuma M; Maekawa T; Nomura T
    Int J Hematol; 1993 Jan; 57(1):15-25. PubMed ID: 8477059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined stratification of refractory anemia according to both WHO and IPSS criteria has a prognostic impact and improves identification of patients who may benefit from stem cell transplantation.
    Cermák J; Vítek A; Michalová K
    Leuk Res; 2004 Jun; 28(6):551-7. PubMed ID: 15120930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen in the treatment of refractory anemia.
    Kobaba R; Kanamaru A; Takemoto Y; Kohsaki M; Kakishita E; Nagai K
    Int J Hematol; 1991 Apr; 54(2):103-7. PubMed ID: 1747444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of aplastic anemia with androgenic anabolic steroids (oxymetholone or methenolone) (author's transl)].
    Matsumoto N; Shinohara K
    Rinsho Ketsueki; 1978 Jul; 19(7):971-6. PubMed ID: 702830
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytogenetic studies in 32 patients with myelodysplastic syndrome: insights to specific chromosomal abnormalities and prognosis.
    Taniwaki M; Horiike S; Inazawa J; Nishida K; Misawa S; Takino T; Abe T
    Jpn J Clin Oncol; 1987 Jun; 17(2):141-50. PubMed ID: 3613138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
    Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
    Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percentages of bone marrow blasts and chromosomal changes in patients with refractory anemia help to determine prognoses.
    Iwabuchi A; Ohyashiki K; Ohyashiki JH; Kimura Y; Lin KY; Aizawa S; Nehashi Y; Miyazawa K; Yaguchi M; Toyama K
    Int J Hematol; 1994 Oct; 60(3):207-13. PubMed ID: 7858240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of primary refractory anemia with a combination regimen of all-trans retinoic acid, calcitriol, and androgen.
    Zhang W; Zhou F; Cao X; Cheng Y; He A; Liu J; Ma X; Chen G
    Leuk Res; 2006 Aug; 30(8):935-42. PubMed ID: 16445979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Refractory anemia and preleukemia: an analysis of 92 cases].
    Xu K; Hao Y
    Zhonghua Xue Ye Xue Za Zhi; 1999 Feb; 20(2):65-8. PubMed ID: 11601200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
    Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
    Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
    Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
    Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.